Two Sigma Securities’s Cyclo Therapeutics, Inc. Common Stock CYTH Stock Holding History

Two Sigma Securities’s Portfolio CYTH Stock Details CYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-42,541	Closed	-$25.1K	–	2371
2024 Q4	$25.1K	Buy	+42,541	New	+$29.5K	﹤0.01%	1277

Two Sigma Securities's CYTH Position: Q1 2025 in Review

Two Sigma Securities sold out of Cyclo Therapeutics, Inc. Common Stock (CYTH) in Q1 2025, closing a stake of 42,541 shares — an estimated $25.1K sold.

Two Sigma Securities first reported a position in CYTH in Q4 2024 and held it in 1 quarter. The position peaked at $25.1K in Q4 2024. 0 funds tracked by Wall St. Rank hold CYTH as of Q1 2025.

Two Sigma Securities reported no remaining Cyclo Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Two Sigma Securities sold 42,541 Cyclo Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $25.1K.
Two Sigma Securities first reported a position in Cyclo Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
Two Sigma Securities's Cyclo Therapeutics, Inc. Common Stock position peaked at $25.1K in Q4 2024.
0 funds tracked by Wall St. Rank held Cyclo Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Two Sigma Securities's 13F filing for Q1 2025, filed 15 May 2025.